• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Titration of individual strains in trivalent live-attenuated influenza vaccine without neutralization

tetano

Editor, Senior Moderator
J Virol Methods. 2016 Sep 2. pii: S0166-0934(16)30301-9. doi: 10.1016/j.jviromet.2016.09.001. [Epub ahead of print]
[h=1]Titration of individual strains in trivalent live-attenuated influenza vaccine without neutralization.[/h] Sirinonthanawech N[SUP]1[/SUP], Surichan S[SUP]2[/SUP], Namsai A[SUP]2[/SUP], Puthavathana P[SUP]3[/SUP], Auewarakul P[SUP]4[/SUP], Kongchanagul A[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Formulation and quality control of trivalent live-attenuated influenza vaccine requires titration of infectivity of individual strains in the trivalent mix. This is usually performed by selective neutralization of two of the three strains and titration of the un-neutralized strain in cell culture or embryonated eggs. This procedure requires standard sera with high neutralizing titer against each of the three strains. Obtaining standard sera, which can specifically neutralize only the corresponding strain of influenza viruses and is able to completely neutralize high concentration of virus in the vaccine samples, can be a problem for many vaccine manufacturers as vaccine stocks usually have very high viral titers and complete neutralization may not be obtained. Here an alternative approach for titration of individual strain in trivalent vaccine without the selective neutralization is presented. This was done by detecting individual strains with specific antibodies in an end-point titration of a trivalent vaccine in cell culture. Similar titers were observed in monovalent and trivalent vaccines for influenza A H3N2 and influenza B strains, whereas the influenza A H1N1 strain did not grow well in cell culture. Viral interference among the vaccine strains was not observed. Therefore, providing that vaccine strains grow well in cell culture, this assay can reliably determine the potency of individual strains in trivalent live-attenuated influenza vaccines.
Copyright ? 2016. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] influenza virus; live-attenuated influenza vaccine; trivalent vaccine titration

PMID: 27596269 DOI: 10.1016/j.jviromet.2016.09.001
[PubMed - as supplied by publisher]
 
Back
Top Bottom